{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:16:36Z","timestamp":1794435396182,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.eclinm.2025.103193","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:23:58Z","timestamp":1744151038000},"page":"103193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022"],"prefix":"10.1016","volume":"83","author":[{"given":"Kexin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingfeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meicen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2078-9056","authenticated-orcid":false,"given":"Wenqiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2025.103193_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103193_bib2","first-page":"489","article-title":"Global patterns and trends in the incidence of non-Hodgkin lymphoma","volume":"30","author":"Miranda-Filho","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103193_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.33948","article-title":"Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040","volume":"150","author":"Singh","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103193_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"issue":"21","key":"10.1016\/j.eclinm.2025.103193_bib5","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.scib.2023.09.041","article-title":"Global, regional, and national lifetime probabilities of developing cancer in 2020","volume":"68","author":"Zheng","year":"2023","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.eclinm.2025.103193_bib6","first-page":"862","article-title":"Cancer incidence in five Continents. Cumulative rate and cumulative risk","volume":"120","author":"Day","year":"1992","journal-title":"IARC Sci Publ"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103193_bib7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.2011.250","article-title":"What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries","volume":"105","author":"Sasieni","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103193_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.2014.606","article-title":"Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960","volume":"112","author":"Ahmad","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eclinm.2025.103193_bib9","series-title":"World population prospects","year":"2019"},{"key":"10.1016\/j.eclinm.2025.103193_bib10","series-title":"Human development index (HDI)","year":"2020"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103193_bib11","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103193_bib13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ijc.34163","article-title":"Global patterns of non-Hodgkin lymphoma in 2020","volume":"151","author":"Mafra","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103193_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103193_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajh.25856","article-title":"Hodgkin lymphoma: a 2020 update on diagnosis, risk-stratification, and management","volume":"95","author":"Ansell","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103193_bib16","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103193_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103193_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232848","article-title":"Hematological malignancies in East Africa-Which cancers to expect and how to provide services","volume":"15","author":"Leak","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103193_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41375-024-02452-y","article-title":"Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022","volume":"39","author":"Daltveit","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.eclinm.2025.103193_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102513","article-title":"Lymphoid blood cancers, incidence and survival 2005-2023: a report from the UK\u2019s Haematological Malignancy Research Network","volume":"88","author":"Lamb","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"10393","key":"10.1016\/j.eclinm.2025.103193_bib21","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103193_bib22","doi-asserted-by":"crossref","first-page":"e854","DOI":"10.1016\/S2352-3026(22)00246-0","article-title":"The influence of drug prices, new availability of inexpensive generic imatinib, new approvals, and post-marketing research on the treatment of chronic myeloid leukaemia in the USA","volume":"9","author":"Kantarjian","year":"2022","journal-title":"Lancet Haematol"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103193_bib23","doi-asserted-by":"crossref","first-page":"e860","DOI":"10.1016\/S2352-3026(23)00164-3","article-title":"Revisiting six established practices in the treatment of chronic myeloid leukaemia","volume":"10","author":"Kantarjian","year":"2023","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103193_bib24","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","article-title":"The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends","volume":"9","author":"Huang","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.eclinm.2025.103193_bib25","first-page":"1","article-title":"Findings of multiple myeloma in afro-caribbean patients in the United States","volume":"4","author":"Banavali","year":"2018","journal-title":"J Glob Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103193_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/bjc.1992.383","article-title":"Cancer mortality in african and caribbean migrants to England and wales","volume":"66","author":"Grulich","year":"1992","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103193_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/jh971","article-title":"Consensus statement: importance of timely access to multiple myeloma diagnosis and treatment in Central America and the caribbean","volume":"11","author":"Pimentel","year":"2022","journal-title":"J Hematol"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103193_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103193_bib29","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1016\/S2352-3026(21)00198-8","article-title":"Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care","volume":"8","author":"Okello","year":"2021","journal-title":"Lancet Haematol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025001257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025001257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:23:52Z","timestamp":1759425832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025001257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"alternative-id":["S2589537025001257"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103193","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103193"}}